# OnCo record pacab-002 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/pacab-002/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "pacab-002" ;
  schema:name "PACAB-002"@en ;
  schema:description "PACAB-002 is an experimental nanoparticle form of the chemotherapy cabazitaxel from NaDeNo Nanoscience, given into the abdomen after ovarian cancer surgery to clear small deposits left behind. Its first trial in people has been approved, and it has orphan status in the European Union for ovarian cancer."@en ;
  schema:url <https://onco.cc/drugs/pacab-002/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.nadeno.com/pacab-002>, <https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-26-3258> ;
  onco:status "preclinical" ;
  onco:tag "pipeline", "orphan-designation" ;
  onco:modality "Nanoparticle formulation of cabazitaxel (intraperitoneal)" ;
  onco:related <https://onco.cc/drugs/cabazitaxel/> ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:companies <https://onco.cc/companies/nadeno-nanoscience/> .